Skip to main content

LGT Group Foundation

Endowment

Position in PFE — Pfizer Inc

CIK 1911278 VADUZ, N2

Position in PFE

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$57,008,312
-$4,942,709 QoQ
Shares Held
2,367,455
+7.3% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
#161
of 2,826 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in PFE Over Time

Shares Held

Position Value (USD)

Derivatives in PFE

reported options exposure · as of Mar 31, 2022
CallValue
$155,310
CallShares
3,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

LGT Group Foundation holds $1,204,398,927 across 9 Drug Manufacturers - General names. PFE ranks #5 (4.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 PFE
Pfizer Inc
This page
2,367,455 $57,008,312

All Filings in PFE

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $57,008,312 2,367,455
2026-03-31 $61,951,021 2,206,233
2025-12-31 $49,533,816 1,989,310
2025-09-30 $50,581,289 1,985,137
2025-06-30 $37,856,041 1,561,718
2025-03-31 $38,856,378 1,533,401
2024-12-31 $24,321,268 916,746
2024-09-30 $22,151,744 765,437
2024-06-30 $20,785,640 742,875
2024-03-31 $20,107,675 724,601
2023-12-31 $19,690,802 683,946
2023-09-30 $24,291,084 732,321
2023-06-30 $28,053,704 764,823
2023-03-31 $30,625,212 750,618
2022-12-31 $38,149,100 744,518
2022-09-30 $23,610,573 539,547
2022-06-30 $38,014,054 725,044
2022-03-31 $30,480,309 588,764
2022-03-31 $155,310 3,000
2021-12-31 $177,150 3,000
2021-12-31 $24,905,693 421,773